Hyperbaric versus isobaric bupivacaine for spinal anaesthesia for caesarean section

Area of Science:

• Anesthesiology
• Obstetric Anesthesia
• Pharmacology

Background:

• Bupivacaine, an amide local anesthetic, is available in hyperbaric and isobaric forms.
• Both forms are administered intrathecally for regional anesthesia during cesarean sections.
• Previous trials comparing these forms have not conclusively demonstrated the superiority of either.

Purpose of the Study:

• To determine the effectiveness of hyperbaric bupivacaine versus isobaric bupivacaine for spinal anesthesia in women undergoing cesarean section.
• To assess the safety profile of hyperbaric bupivacaine compared to isobaric bupivacaine in this patient population.

Main Methods:

• Systematic review and meta-analysis of randomized controlled trials (RCTs).
• Searched CENTRAL, MEDLINE, and Embase databases from inception to March 2016.
• Included 10 RCTs with 614 participants comparing hyperbaric and isobaric bupivacaine for spinal anesthesia in cesarean section.

Main Results:

• Hyperbaric bupivacaine demonstrated a more rapid onset of sensory block to the T4 level (moderate quality evidence).
• No significant differences were found in the need for conversion to general anesthesia (very low quality evidence) or supplemental analgesics (very low quality evidence).
• Adverse effects such as nausea, vomiting, and headache did not differ significantly between the two forms (low quality evidence).

Conclusions:

• Intrathecal hyperbaric bupivacaine provides a faster onset of sensory blockade compared to isobaric bupivacaine.
• Despite the faster onset, there is limited evidence of significant differences in overall effectiveness or safety outcomes.
• Larger RCTs with standardized criteria for conversion to general anesthesia are needed to confirm any potential advantages.